K. Carroll

发表

Treatment of malignant pleural effusions with intrapleural Corynebacterium parvum or tetracycline.

T. B. Stretton, N. Thatcher, D. Honeybourne, 1985, European journal of respiratory diseases.

Treatment of small cell lung carcinoma in association with cryptogenic fibrosing alveolitis

J. Winstanley, N. Thatcher, J. Lipton, 1982, Postgraduate medical journal.

11-WEEK COURSE OF SEQUENTIAL METHOTREXATE, THORACIC IRRADIATION, AND MODERATE-DOSE CYCLOPHOSPHAMIDE FOR "LIMITED"-STAGE SMALL-CELL BRONCHOGENIC CARCINOMA A Study from the Manchester Lung Tumour Group

P. Wilkinson, D. Crowther, N. Thatcher, 1982, The Lancet.

High dose combination chemotherapy with ifosfamide, cyclophosphamide or cisplatin, mitomycin C and mustine with autologous bone marrow support in advanced non-small cell lung cancer. A phase I/II study.

N. Thatcher, J. Chang, S. Gomm, 1991, British Journal of Cancer.

Three months treatment with chemotherapy and radiotherapy for small cell lung cancer.

N. Thatcher, D. Smith, R. Stout, 1985, British Journal of Cancer.

Moderate to high dose cyclophosphamide and intercalated Corynebacterium parvum in patients with metastatic lung cancer.

D. Crowther, N. Thatcher, J. Wagstaff, 1984, British journal of diseases of the chest.

Therapy for poor-risk patients with small-cell lung cancer using bolus ifosfamide and oral etoposide

A. Woodcock, N. Thatcher, R. Swindell, 2008, Cancer Chemotherapy and Pharmacology.

Carboplatin, ifosfamide and etoposide with mid-course vincristine and thoracic radiotherapy for 'limited' stage small cell carcinoma of the bronchus.

N. Thatcher, M. Lind, C. Campbell, 1989, British Journal of Cancer.

A comparison between a single agent short course chemotherapy regimen and a quadruple prolonged course regimen for small-cell bronchogenic carcinoma of limited extent.

N. Thatcher, D. Brown, K. Carroll, 1983, British journal of diseases of the chest.